Works matching IS 09509232 AND DT 2011 AND VI 30 AND IP 19

Results: 11

Inhibition of androgen receptor activity by histone deacetylase 4 through receptor SUMOylation.

Published in:

Oncogene, 2011, v. 30, n. 19, p. 2207, doi. 10.1038/onc.2010.600

By:

Yang, Y;
Tse, A K-W;
Li, P;
Ma, Q;
Xiang, S;
Nicosia, S V;
Seto, E;
Zhang, X;
Bai, W

Publication type:

Article

TGF-β1 signaling targets metastasis-associated protein 1, a new effector in epithelial cells.

Published in:

Oncogene, 2011, v. 30, n. 19, p. 2230, doi. 10.1038/onc.2010.608

By:

Pakala, S B;
Singh, K;
Reddy, S D N;
Ohshiro, K;
Li, D-Q;
Mishra, L;
Kumar, R

Publication type:

Article

Activated ROCK II by-passes the requirement of the CDK2 activity for centrosome duplication and amplification.

Published in:

Oncogene, 2011, v. 30, n. 19, p. 2188, doi. 10.1038/onc.2010.607

By:

Hanashiro, K;
Brancaccio, M;
Fukasawa, K

Publication type:

Article

Translationally controlled tumor protein induces human breast epithelial cell transformation through the activation of Src.

Published in:

Oncogene, 2011, v. 30, n. 19, p. 2264, doi. 10.1038/onc.2010.604

By:

Jung, J;
Kim, H Y;
Kim, M;
Sohn, K;
Lee, K

Publication type:

Article

c-Cbl inhibits angiogenesis and tumor growth by suppressing activation of PLCγ1.

Published in:

Oncogene, 2011, v. 30, n. 19, p. 2198, doi. 10.1038/onc.2010.597

By:

Meyer, R D;
Husain, D;
Rahimi, N

Publication type:

Article

hTID-1 defines a novel regulator of c-Met Receptor signaling in renal cell carcinomas.

Published in:

Oncogene, 2011, v. 30, n. 19, p. 2252, doi. 10.1038/onc.2010.601

By:

Copeland, E;
Balgobin, S;
Lee, C M;
Rozakis-Adcock, M

Publication type:

Article

Cdc25B is negatively regulated by p53 through Sp1 and NF-Y transcription factors.

Published in:

Oncogene, 2011, v. 30, n. 19, p. 2282, doi. 10.1038/onc.2010.588

By:

Dalvai, M;
Mondesert, O;
Bourdon, J-C;
Ducommun, B;
Dozier, C

Publication type:

Article

Histone deacetylase inhibitors prime medulloblastoma cells for chemotherapy-induced apoptosis by enhancing p53-dependent Bax activation.

Published in:

Oncogene, 2011, v. 30, n. 19, p. 2275, doi. 10.1038/onc.2010.599

By:

Häcker, S;
Karl, S;
Mader, I;
Cristofanon, S;
Schweitzer, T;
Krauss, J;
Rutkowski, S;
Debatin, K-M;
Fulda, S

Publication type:

Article

hSSB1 binds and protects p21 from ubiquitin-mediated degradation and positively correlates with p21 in human hepatocellular carcinomas.

Published in:

Oncogene, 2011, v. 30, n. 19, p. 2219, doi. 10.1038/onc.2010.596

By:

Xu, S;
Feng, Z;
Zhang, M;
Wu, Y;
Sang, Y;
Xu, H;
Lv, X;
Hu, K;
Cao, J;
Zhang, R;
Chen, L;
Liu, M;
Yun, J-P;
Zeng, Y-X;
Kang, T

Publication type:

Article

Myc/miR-378/TOB2/cyclin D1 functional module regulates oncogenic transformation.

Published in:

Oncogene, 2011, v. 30, n. 19, p. 2242, doi. 10.1038/onc.2010.602

By:

Feng, M;
Li, Z;
Aau, M;
Wong, C H;
Yang, X;
Yu, Q

Publication type:

Article

Professor Alan M Gewirtz (1949-2010).

Published in:

Oncogene, 2011, v. 30, n. 19, p. 2187, doi. 10.1038/onc.2011.78

By:

Bender, T P;
Gonda, T J;
Frampton, J;
Ness, S A;
Ramsay, R G

Publication type:

Article